{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T18:55:03Z","timestamp":1793300103617,"version":"4.5.0"},"reference-count":100,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"vor","delay-in-days":83,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:00:00Z","timestamp":1764201600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>In the past decade, advancements in knowledge on the immune system have partially unveiled the complex interplay between the heart and the immune system. This new branch of cardiology is now called cardio-immunology. It encompasses different areas from preclinical to translational and purely clinical research aiming to identify the relationship between the immune system and different cardiovascular diseases. Inflammatory cardiomyopathies are a heterogeneous subgroup of non-ischaemic cardiomyopathies characterized by left ventricular, or biventricular, dysfunction after an inflammatory insult. Recently, genetic testing allowed to identify specific genotype\u2013phenotype correlation in the diagnosis and, mostly, in the prognosis of different cardiomyopathies. Some pathogenic variants might lead to a clinical phenotype in overlap with inflammatory myocardial diseases and inflammation can be found in cardiac magnetic resonance or endomyocardial biopsies of different cardiomyopathies. Although prognostic predictors of adverse events and indication to immunosuppressive therapies have been identified in myocarditis, data are lacking in the context of genetic cardiomyopathies presenting myocardial inflammation. As for pericardial diseases, genetic variants in immune-related genes, such as IL1B have been described, specifically in recurrent pericarditis. A growing body of evidence starting form genetics and cardio-immunology are trying to elucidate the basic mechanisms of the disease and may play a significant role in the understanding the pathophysiology and potentially the treatment of patients. Some examples are represented by arrhythmogenic cardiomyopathy presenting with hot-phases or biopsy-proven myocarditis presenting genetic mutations in specific genes as TTN or DSP. The aim of this review paper is to highlight the current knowledge and the unmet clinical needs, providing a practical and concise guidance for specific areas of research and management of patients affected by myo-pericardial diseases with overlap between genetics and inflammation, ranging from genetic testing to medical and device therapy.<\/jats:p>","DOI":"10.1002\/ehf2.15231","type":"journal-article","created":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T14:41:07Z","timestamp":1764254467000},"page":"3987-3999","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Inflammation and Genetics in Myo-Pericardial Diseases: Insights from the Italian Study Group on Cardiomyopathies and Pericardial Diseases"],"prefix":"10.1093","volume":"12","author":[{"given":"Marco","family":"Merlo","sequence":"first","affiliation":[{"name":"Centre for Diagnosis and Treatment of Cardiomyopathies, Cardiovascular Department, Azienda Sanitaria Universitaria Giuliano-Isontina (ASUGI), European Reference Network for Rare, Low Prevalence and Complex Diseases of the Heart (ERN GUARD-Heart) , Trieste ,","place":["Italy"]},{"name":"University of Trieste , Trieste ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Bassetto","sequence":"additional","affiliation":[{"name":"Centre for Diagnosis and Treatment of Cardiomyopathies, Cardiovascular Department, Azienda Sanitaria Universitaria Giuliano-Isontina (ASUGI), European Reference Network for Rare, Low Prevalence and Complex Diseases of the Heart (ERN GUARD-Heart) , Trieste ,","place":["Italy"]},{"name":"University of Trieste , Trieste ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Cannat\u00e0","sequence":"additional","affiliation":[{"name":"Centre for Diagnosis and Treatment of Cardiomyopathies, Cardiovascular Department, Azienda Sanitaria Universitaria Giuliano-Isontina (ASUGI), European Reference Network for Rare, Low Prevalence and Complex Diseases of the Heart (ERN GUARD-Heart) , Trieste ,","place":["Italy"]},{"name":"University of Trieste , Trieste ,","place":["Italy"]},{"name":"Department of Cardiology, King's College Hospital , London ,","place":["UK"]},{"name":"School of Cardiovascular and Metabolic Medicine & Sciences, British Heart Foundation Centre of Excellence, King's College London, James Black Centre , London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Aimo","sequence":"additional","affiliation":[{"name":"Scuola Superiore Sant'Anna, Fondazione Monasterio , Pisa ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camillo","family":"Autore","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Respiratory Sciences, San Raffaele Cassino , Cassino ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Bauce","sequence":"additional","affiliation":[{"name":"Department of Cardiac, Thoracic and Vascular Sciences and Public Health, European Reference Network for Rare, Low Prevalence and Complex Diseases of the Heart (ERN GUARD-Heart), University of Padua , Padua ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Biagini","sequence":"additional","affiliation":[{"name":"IRCSS Azienda Ospedaliero\u2013Universitaria di Bologna , Bologna ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Cappelli","sequence":"additional","affiliation":[{"name":"Tuscan Regional Amyloidosis Centre, Careggi University Hospital , Florence ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Castelletti","sequence":"additional","affiliation":[{"name":"Cardiology Department, Istituto Auxologico Italiano IRCSS , Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavio","family":"D'Ascenzi","sequence":"additional","affiliation":[{"name":"Department of Medical Biotechnologies, Division of Cardiology, University of Siena , Siena ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesare","family":"de Gregorio","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, University Hospital of Messina , Messina ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Limongelli","sequence":"additional","affiliation":[{"name":"Inherited and Rare Cardiovascular Diseases, Department of Translational Medical Sciences, European Reference Network for Rare, Low Prevalence and Complex Diseases of the Heart (ERN GUARD-Heart), University of Campania Luigi Vanvitelli, Monaldi Hospital , Naples ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Marzo","sequence":"additional","affiliation":[{"name":"Cardiology Unit, Infermi Hospital , Rimini ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Musumeci","sequence":"additional","affiliation":[{"name":"Department of Clinical and Molecular Medicine, Sapienza University , Rome ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Tini","sequence":"additional","affiliation":[{"name":"Department of Clinical and Molecular Medicine, Sapienza University , Rome ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Pedrinelli","sequence":"additional","affiliation":[{"name":"Cardiac, Thoracic and Vascular Department, University of Pisa , Pisa ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale Perrone","family":"Filardi","sequence":"additional","affiliation":[{"name":"Department of Advanced Biomedical Sciences, Italian Society of Cardiology, Federico II University of Naples , Naples ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianfranco","family":"Sinagra","sequence":"additional","affiliation":[{"name":"Centre for Diagnosis and Treatment of Cardiomyopathies, Cardiovascular Department, Azienda Sanitaria Universitaria Giuliano-Isontina (ASUGI), European Reference Network for Rare, Low Prevalence and Complex Diseases of the Heart (ERN GUARD-Heart) , Trieste ,","place":["Italy"]},{"name":"University of Trieste , Trieste ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Imazio","sequence":"additional","affiliation":[{"name":"Department of Medicine (DMED), University of Udine , Udine ,","place":["Italy"]},{"name":"Cardiothoracic Department, University Hospital Santa Maria della Misericordia, ASUFC , Udine ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,11,27]]},"reference":[{"key":"2026021804212697200_ehf215231-bib-0001","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1161\/CIRCRESAHA.110.226936","article-title":"The emerging role of innate immunity in the heart and vascular system","volume":"108","author":"Mann","year":"2011","journal-title":"Circ Res"},{"key":"2026021804212697200_ehf215231-bib-0002","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/s41569-021-00668-4","article-title":"Therapeutic strategies targeting inflammation and immunity in atherosclerosis: how to proceed?","volume":"19","author":"Engelen","year":"2022","journal-title":"Nat Rev Cardiol"},{"key":"2026021804212697200_ehf215231-bib-0003","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1002\/ejhf.1138","article-title":"The innate immune system in chronic cardiomyopathy: a European Society of Cardiology (ESC) scientific statement from the Working Group on Myocardial Function of the ESC","volume":"20","author":"Frantz","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"2026021804212697200_ehf215231-bib-0004","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1016\/j.jacc.2016.09.937","article-title":"The quest for new approaches in myocarditis and inflammatory cardiomyopathy","volume":"68","author":"Heymans","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"2026021804212697200_ehf215231-bib-0005","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/S0008-6363(00)00142-5","article-title":"Myocardial expression of CC- and CXC-chemokines and their receptors in human end-stage heart failure","volume":"47","author":"Dam\u00e5s","year":"2000","journal-title":"Cardiovasc Res"},{"key":"2026021804212697200_ehf215231-bib-0006","first-page":"CR478","article-title":"Phenotypic characterization of infiltrates in dilated cardiomyopathy\u2014diagnostic significance of T-lymphocytes and macrophages in inflammatory cardiomyopathy","volume":"8","author":"Noutsias","journal-title":"Med Sci Monit"},{"key":"2026021804212697200_ehf215231-bib-0007","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.321.7258.424","article-title":"Th1 and Th2 responses: what are they?","volume":"321","author":"Berger","year":"2000","journal-title":"BMJ"},{"key":"2026021804212697200_ehf215231-bib-0008","doi-asserted-by":"publisher","first-page":"2910","DOI":"10.1161\/01.CIR.0000147538.92263.3A","article-title":"Novel model of constrictive pericarditis associated with autoimmune heart disease in interferon-gamma-knockout mice","volume":"110","author":"Afanasyeva","year":"2004","journal-title":"Circulation"},{"key":"2026021804212697200_ehf215231-bib-0009","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.85851","article-title":"Cardiac myosin-Th17 responses promote heart failure in human myocarditis","volume":"1","author":"Myers","journal-title":"JCI Insight"},{"key":"2026021804212697200_ehf215231-bib-0010","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/j.jacc.2020.01.014","article-title":"Inflammation in heart failure: JACC state-of-the-art review","volume":"75","author":"Murphy","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2026021804212697200_ehf215231-bib-0011","doi-asserted-by":"publisher","DOI":"10.1136\/openhrt-2023-002360","article-title":"Colchicine in patients with heart failure and preserved left ventricular ejection fraction: rationale and design of a prospective, randomised, open-label, crossover clinical trial","volume":"10","author":"Shchendrygina","year":"2023","journal-title":"Open Heart"},{"key":"2026021804212697200_ehf215231-bib-0012","article-title":"Effects of COLchicine on inflammation, myocardial damage and microvascular dysfunction in heart failure with Preserved Ejection Fraction\u2014the COLpEF trial","volume":"15","author":"Bourcier","year":"2023","journal-title":"Arch Cardiovasc Dis Suppl"},{"key":"2026021804212697200_ehf215231-bib-0013","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2023.10.024","article-title":"HERMES: effects of Ziltivekimab versus placebo on morbidity and mortality in patients with heart failure with mildly reduced or preserved ejection fraction and systemic inflammation","volume":"30","author":"Petrie","year":"2024","journal-title":"J Card Fail"},{"key":"2026021804212697200_ehf215231-bib-0014","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N Engl J Med"},{"key":"2026021804212697200_ehf215231-bib-0015","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1161\/CIRCRESAHA.120.315937","article-title":"Interleukin-1 and the Inflammasome as therapeutic targets in cardiovascular disease","volume":"126","author":"Abbate","year":"2020","journal-title":"Circ Res"},{"key":"2026021804212697200_ehf215231-bib-0016","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jacc.2013.02.092","article-title":"A novel paradigm for heart failure with preserved ejection fraction","volume":"62","author":"Paulus","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"2026021804212697200_ehf215231-bib-0017","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1038\/s41577-018-0065-8","article-title":"Cardioimmunology: the immune system in cardiac homeostasis and disease","volume":"18","author":"Swirski","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"2026021804212697200_ehf215231-bib-0018","doi-asserted-by":"publisher","first-page":"H1025","DOI":"10.1152\/ajpheart.00795.2013","article-title":"Interleukin-18 mediates interleukin-1-induced cardiac dysfunction","volume":"306","author":"Toldo","year":"2014","journal-title":"Am J Phys Heart Circ Phys"},{"key":"2026021804212697200_ehf215231-bib-0019","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1056\/NEJM199007263230405","article-title":"Elevated circulating levels of tumor necrosis factor in severe chronic heart failure","volume":"323","author":"Levine","year":"1990","journal-title":"N Engl J Med"},{"key":"2026021804212697200_ehf215231-bib-0020","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/0735-1097(95)00589-7","article-title":"Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD)","volume":"27","author":"Torre-Amione","year":"1996","journal-title":"J Am Coll Cardiol"},{"key":"2026021804212697200_ehf215231-bib-0021","doi-asserted-by":"publisher","first-page":"3133","DOI":"10.1161\/01.CIR.0000077913.60364.D2","article-title":"Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-\u03b1, in patients with moderate-to-severe heart failure","volume":"107","author":"Chung","year":"2003","journal-title":"Circulation"},{"key":"2026021804212697200_ehf215231-bib-0022","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1161\/01.CIR.0000124490.27666.B2","article-title":"Targeted anticytokine therapy in patients with chronic heart failure","volume":"109","author":"Mann","year":"2004","journal-title":"Circulation"},{"key":"2026021804212697200_ehf215231-bib-0023","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1016\/j.jacc.2009.12.045","article-title":"Inflammatory markers and incident heart failure risk in older adults: the Health ABC (Health, Aging, and Body Composition) study","volume":"55","author":"Kalogeropoulos","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"2026021804212697200_ehf215231-bib-0024","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.122.010051","article-title":"Adverse outcomes associated with Interleukin-6 in patients recently hospitalized for heart failure with preserved ejection fraction","volume":"16","author":"Mooney","year":"2023","journal-title":"Circ Heart Fail"},{"key":"2026021804212697200_ehf215231-bib-0025","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.jjcc.2021.03.003","article-title":"Pathological and clinical effects of interleukin-6 on human myocarditis","volume":"78","author":"Amioka","year":"2021","journal-title":"J Cardiol"},{"key":"2026021804212697200_ehf215231-bib-0026","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1017\/cts.2017.11","article-title":"Diagnostic accuracy of damage-associated molecular patterns (DAMPs) in patients with heart failure with a reduced ejection fraction","volume":"1","author":"Hartupee","year":"2017","journal-title":"J Clin Transl Sci"},{"key":"2026021804212697200_ehf215231-bib-0027","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1016\/j.jacc.2019.08.1039","article-title":"Clinical and prognostic significance of sST2 in heart failure","volume":"74","author":"Aimo","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2026021804212697200_ehf215231-bib-0028","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1097\/MED.0b013e3283391989","article-title":"Aldosterone and inflammation","volume":"17","author":"Gilbert","year":"2010","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"2026021804212697200_ehf215231-bib-0029","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1161\/CIRCRESAHA.111.243360","article-title":"Autoantibodies in heart failure and cardiac dysfunction","volume":"110","author":"Kaya","year":"2012","journal-title":"Circ Res"},{"key":"2026021804212697200_ehf215231-bib-0030","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1161\/CIRCULATIONAHA.106.641472","article-title":"Prospective familial assessment in dilated cardiomyopathy","volume":"115","author":"Caforio","year":"2007","journal-title":"Circulation"},{"key":"2026021804212697200_ehf215231-bib-0031","doi-asserted-by":"publisher","DOI":"10.3390\/biom13040646","article-title":"Myocardial inflammation as a manifestation of genetic cardiomyopathies: from bedside to the bench","volume":"13","author":"Peretto","year":"2023","journal-title":"Biomol Ther"},{"key":"2026021804212697200_ehf215231-bib-0032","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1093\/eurheartj\/eht210","article-title":"Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases","volume":"34","author":"Caforio","year":"2013","journal-title":"Eur Heart J"},{"key":"2026021804212697200_ehf215231-bib-0033","doi-asserted-by":"publisher","first-page":"2384","DOI":"10.1161\/CIRCULATIONAHA.113.003092","article-title":"Long-term evolution and prognostic stratification of biopsy-proven active myocarditis","volume":"128","author":"Anzini","year":"2013","journal-title":"Circulation"},{"key":"2026021804212697200_ehf215231-bib-0034","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1016\/j.jacc.2012.01.007","article-title":"Long-term follow-up of biopsy-proven viral myocarditis: predictors of mortality and incomplete recovery","volume":"59","author":"Gr\u00fcn","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"2026021804212697200_ehf215231-bib-0035","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1093\/eurheartj\/ehad778","article-title":"Dilated cardiomyopathy: second hits knock-down the heart","volume":"45","author":"Verdonschot","year":"2024","journal-title":"Eur Heart J"},{"key":"2026021804212697200_ehf215231-bib-0036","doi-asserted-by":"publisher","first-page":"B90","DOI":"10.1093\/eurheartj\/suz033","article-title":"Myocarditis evolving in cardiomyopathy: when genetics and offending causes work together","volume":"21","author":"Cannata'","year":"2019","journal-title":"Eur Heart J Suppl J Eur Soc Cardiol"},{"key":"2026021804212697200_ehf215231-bib-0037","doi-asserted-by":"publisher","DOI":"10.1007\/s00395-014-0449-2","article-title":"Interleukin-6 receptor inhibition modulates the immune reaction and restores titin phosphorylation in experimental myocarditis","volume":"109","author":"Savvatis","year":"2014","journal-title":"Basic Res Cardiol"},{"key":"2026021804212697200_ehf215231-bib-0038","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1093\/cvr\/cvt144","article-title":"Differential changes in titin domain phosphorylation increase myofilament stiffness in failing human hearts","volume":"99","author":"K\u00f6tter","year":"2013","journal-title":"Cardiovasc Res"},{"key":"2026021804212697200_ehf215231-bib-0039","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.jacbts.2022.12.013","article-title":"Bag3 regulates mitochondrial function and the inflammasome through canonical and noncanonical pathways in the heart","volume":"8","author":"Wang","year":"2023","journal-title":"JACC Basic Transl Sci"},{"key":"2026021804212697200_ehf215231-bib-0040","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1038\/nm737","article-title":"Dystrophin deficiency markedly increases enterovirus-induced cardiomyopathy: a genetic predisposition to viral heart disease","volume":"8","author":"Xiong","year":"2002","journal-title":"Nat Med"},{"key":"2026021804212697200_ehf215231-bib-0041","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1172\/JCI64098","article-title":"Cellular senescence and the senescent secretory phenotype: therapeutic opportunities","volume":"123","author":"Tchkonia","year":"2013","journal-title":"J Clin Invest"},{"key":"2026021804212697200_ehf215231-bib-0042","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2377-10-33","article-title":"Myocardial inflammation in Duchenne muscular dystrophy as a precipitating factor for heart failure: a prospective study","volume":"10","author":"Mavrogeni","year":"2010","journal-title":"BMC Neurol"},{"key":"2026021804212697200_ehf215231-bib-0043","article-title":"Central role for GSK3\u03b2 in the pathogenesis of arrhythmogenic cardiomyopathy","volume":"1","author":"Chelko","journal-title":"JCI Insight"},{"key":"2026021804212697200_ehf215231-bib-0044","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1161\/01.CIR.94.5.983","article-title":"Arrhythmogenic right ventricular cardiomyopathy","volume":"94","author":"Basso","year":"1996","journal-title":"Circulation"},{"key":"2026021804212697200_ehf215231-bib-0045","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1161\/CIRCULATIONAHA.119.044934","article-title":"Desmoplakin cardiomyopathy, a fibrotic and inflammatory form of cardiomyopathy distinct from typical dilated or Arrhythmogenic right ventricular cardiomyopathy","volume":"141","author":"Smith","year":"2020","journal-title":"Circulation"},{"key":"2026021804212697200_ehf215231-bib-0046","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacadv.2024.100832","article-title":"Long-term arrhythmic follow-up and risk stratification of patients with desmoplakin-associated arrhythmogenic right ventricular cardiomyopathy","volume":"3","author":"Gasperetti","year":"2024","journal-title":"JACC Adv"},{"key":"2026021804212697200_ehf215231-bib-0047","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1093\/europace\/euaa343","article-title":"\u2018Hot phase\u2019 clinical presentation in arrhythmogenic cardiomyopathy","volume":"23","author":"Bariani","year":"2021","journal-title":"EP Eur"},{"key":"2026021804212697200_ehf215231-bib-0048","doi-asserted-by":"publisher","DOI":"10.3390\/biom12091324","article-title":"Myocarditis-like episodes in patients with arrhythmogenic cardiomyopathy: a systematic review on the so-called hot-phase of the disease","volume":"12","author":"Bariani","year":"2022","journal-title":"Biomol Ther"},{"key":"2026021804212697200_ehf215231-bib-0049","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1002\/ejhf.3173","article-title":"Apoptosis, a useful marker in the management of hot-phase cardiomyopathy?","volume":"26","author":"Bassetto","year":"2024","journal-title":"Eur J Heart Fail"},{"key":"2026021804212697200_ehf215231-bib-0050","doi-asserted-by":"publisher","DOI":"10.1016\/j.carpath.2022.107494","article-title":"Diagnosing myocarditis in endomyocardial biopsies: survey of current practice","volume":"64","author":"De Gaspari","year":"2023","journal-title":"Cardiovasc Pathol Off J Soc Cardiovasc Pathol"},{"key":"2026021804212697200_ehf215231-bib-0051","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ijcard.2021.02.068","article-title":"Positron emission tomography in clinically suspected myocarditis\u2014STREAM study design","volume":"1","author":"Oziera\u0144ski","year":"2021","journal-title":"Int J Cardiol"},{"key":"2026021804212697200_ehf215231-bib-0052","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2024.10.080","article-title":"ACC expert consensus decision pathway on strategies and criteria for the diagnosis and management of myocarditis","author":"Drazner","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"2026021804212697200_ehf215231-bib-0053","doi-asserted-by":"crossref","first-page":"3098","DOI":"10.1016\/j.jacc.2020.04.048","article-title":"Lymphocytic myocarditis","volume":"75","author":"Artico","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2026021804212697200_ehf215231-bib-0054","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.cjca.2022.01.004","article-title":"Myocardial inflammation and sudden death in the inherited cardiomyopathies","volume":"38","author":"McKenna","year":"2022","journal-title":"Can J Cardiol"},{"key":"2026021804212697200_ehf215231-bib-0055","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1253\/circj.CJ-17-1235","article-title":"High signal intensity on T2-weighted cardiovascular magnetic resonance imaging predicts life-threatening arrhythmic events in hypertrophic cardiomyopathy patients","volume":"82","author":"Hen","year":"2018","journal-title":"Circ J"},{"key":"2026021804212697200_ehf215231-bib-0056","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1016\/j.jcmg.2023.06.011","article-title":"Correlations between cardiac magnetic resonance and myocardial histologic findings in Fabry disease","volume":"16","author":"Ditaranto","year":"2023","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026021804212697200_ehf215231-bib-0057","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.ymgme.2017.09.004","article-title":"Contribution of inflammatory pathways to Fabry disease pathogenesis","volume":"122","author":"Rozenfeld","year":"2017","journal-title":"Mol Genet Metab"},{"key":"2026021804212697200_ehf215231-bib-0058","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1093\/eurheartj\/ehx321","article-title":"Diagnosis and management of myocardial involvement in systemic immune-mediated diseases: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Disease","volume":"38","author":"Caforio","year":"2017","journal-title":"Eur Heart J"},{"key":"2026021804212697200_ehf215231-bib-0059","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1161\/CIRCULATIONAHA.119.043931","article-title":"Evidence from family studies for autoimmunity in arrhythmogenic right ventricular cardiomyopathy: associations of circulating anti-heart and anti-intercalated disk autoantibodies with disease severity and family history","volume":"141","author":"Caforio","year":"2020","journal-title":"Circulation"},{"key":"2026021804212697200_ehf215231-bib-0060","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1126\/science.aav3487","article-title":"Microbiota-derived peptide mimics drive lethal inflammatory cardiomyopathy","volume":"366","author":"Gil-Cruz","year":"2019","journal-title":"Science"},{"key":"2026021804212697200_ehf215231-bib-0061","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.chom.2019.12.011","article-title":"Gut bacteria\u2014not for the faint of heart","volume":"27","author":"Mandelbaum","year":"2020","journal-title":"Cell Host Microbe"},{"issue":"36","key":"2026021804212697200_ehf215231-bib-0062","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"2026021804212697200_ehf215231-bib-0063","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/j.jacc.2017.01.043","article-title":"Autosomal recessive cardiomyopathy presenting as acute myocarditis","volume":"69","author":"Belkaya","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2026021804212697200_ehf215231-bib-0064","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1161\/CIRCULATIONAHA.121.058457","article-title":"Genetic architecture of acute myocarditis and the overlap with inherited cardiomyopathy","volume":"146","author":"Lota","year":"2022","journal-title":"Circulation"},{"key":"2026021804212697200_ehf215231-bib-0065","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/j.jchf.2024.02.012","article-title":"Prevalence of pathogenic variants in cardiomyopathy-associated genes in acute myocarditis","volume":"12","author":"Monda","year":"2024","journal-title":"JACC Heart Fail"},{"key":"2026021804212697200_ehf215231-bib-0066","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.121.008443","article-title":"BAG3 genetic cardiomyopathy may overlap fulminant myocarditis clinical findings","volume":"15","author":"Jord\u00e0","year":"2022","journal-title":"Circ Heart Fail"},{"key":"2026021804212697200_ehf215231-bib-0067","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/ng720","article-title":"CARD15 mutations in Blau syndrome","volume":"29","author":"Miceli-Richard","year":"2001","journal-title":"Nat Genet"},{"key":"2026021804212697200_ehf215231-bib-0068","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.ijcard.2005.03.075","article-title":"Gene expression in giant cell myocarditis: altered expression of immune response genes","volume":"102","author":"Kittleson","year":"2005","journal-title":"Int J Cardiol"},{"key":"2026021804212697200_ehf215231-bib-0069","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/978-3-030-35276-9_4","article-title":"Genetic basis of myocarditis: myth or reality?","author":"Arbustini","year":"2020","journal-title":"Myocarditis"},{"key":"2026021804212697200_ehf215231-bib-0070","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1016\/j.cjca.2023.04.008","article-title":"New developments in the management of recurrent pericarditis","volume":"39","author":"Imazio","year":"2023","journal-title":"Can J Cardiol"},{"key":"2026021804212697200_ehf215231-bib-0071","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s00392-012-0422-8","article-title":"Clues to detect tumor necrosis factor receptor-associated periodic syndrome (TRAPS) among patients with idiopathic recurrent acute pericarditis: results of a multicentre study","volume":"101","author":"Cantarini","year":"2012","journal-title":"Clin Res Cardiol Off J Ger Card Soc"},{"key":"2026021804212697200_ehf215231-bib-0072","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.121.024931","article-title":"Pericarditis and autoinflammation: a clinical and genetic analysis of patients with idiopathic recurrent pericarditis and monogenic autoinflammatory diseases at a national referral center","volume":"11","author":"Peet","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"2026021804212697200_ehf215231-bib-0073","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1001\/jamacardio.2023.4820","article-title":"Variants at the interleukin 1 gene locus and pericarditis","volume":"9","author":"Thorolfsdottir","year":"2024","journal-title":"JAMA Cardiol"},{"key":"2026021804212697200_ehf215231-bib-0074","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s12016-010-8219-x","article-title":"Role of autoimmunity and autoinflammation in the pathogenesis of idiopathic recurrent pericarditis","volume":"44","author":"Cantarini","year":"2013","journal-title":"Clin Rev Allergy Immunol"},{"key":"2026021804212697200_ehf215231-bib-0075","doi-asserted-by":"publisher","first-page":"212","DOI":"10.4274\/balkanmedj.galenos.2019.2019.5.62","article-title":"Kounis syndrome\u2014not a single-organ arterial disorder but a multisystem and multidisciplinary disease","volume":"36","author":"Kounis","year":"2019","journal-title":"Balkan Med J"},{"key":"2026021804212697200_ehf215231-bib-0076","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/s41586-020-2588-y","article-title":"Longitudinal analyses reveal immunological misfiring in severe COVID-19","volume":"584","author":"Lucas","year":"2020","journal-title":"Nature"},{"key":"2026021804212697200_ehf215231-bib-0077","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9030221","article-title":"Allergic reactions to current available COVID-19 vaccinations: pathophysiology, causality, and therapeutic considerations","volume":"9","author":"Kounis","year":"2021","journal-title":"Vaccines"},{"key":"2026021804212697200_ehf215231-bib-0078","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"2026021804212697200_ehf215231-bib-0079","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/s41569-023-00919-6","article-title":"Immunomodulation and immunopharmacology in heart failure","volume":"21","author":"Markousis-Mavrogenis","year":"2024","journal-title":"Nat Rev Cardiol"},{"key":"2026021804212697200_ehf215231-bib-0080","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/9944880","article-title":"Anti-inflammatory effects of empagliflozin and gemigliptin on LPS-stimulated macrophage via the IKK\/NF-\u03baB, MKK7\/JNK, and JAK2\/STAT1 signalling pathways","volume":"2021","author":"Lee","year":"2021","journal-title":"J Immunol Res"},{"key":"2026021804212697200_ehf215231-bib-0081","article-title":"Immunomodulating therapies in acute myocarditis and recurrent\/acute pericarditis","volume":"7","author":"Ammirati","year":"2022","journal-title":"Front Med"},{"key":"2026021804212697200_ehf215231-bib-0082","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1093\/eurheartj\/ehp249","article-title":"Randomized study on the efficacy of immunosuppressive therapy in patients with virus-negative inflammatory cardiomyopathy: the TIMIC study","volume":"30","author":"Frustaci","year":"2009","journal-title":"Eur Heart J"},{"key":"2026021804212697200_ehf215231-bib-0083","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102710","article-title":"Efficacy of immunosuppressive therapy in myocarditis: a 30-year systematic review and meta analysis","volume":"20","author":"Cheng","year":"2021","journal-title":"Autoimmun Rev"},{"key":"2026021804212697200_ehf215231-bib-0084","doi-asserted-by":"publisher","first-page":"3463","DOI":"10.1093\/eurheartj\/ehac348","article-title":"Immunosuppressive therapy in virus-negative inflammatory cardiomyopathy: 20-year follow-up of the TIMIC trial","volume":"43","author":"Chimenti","year":"2022","journal-title":"Eur Heart J"},{"key":"2026021804212697200_ehf215231-bib-0085","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1001\/jama.2016.15826","article-title":"Effect of anakinra on recurrent pericarditis among patients with colchicine resistance and corticosteroid dependence: the AIRTRIP randomized clinical trial","volume":"316","author":"Brucato","year":"2016","journal-title":"JAMA"},{"key":"2026021804212697200_ehf215231-bib-0086","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.117.004373","article-title":"Interleukin-1 blockade in recently decompensated systolic heart failure","volume":"10","author":"Van Tassell","year":"2017","journal-title":"Circ Heart Fail"},{"key":"2026021804212697200_ehf215231-bib-0087","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-022-03466-9","article-title":"Rationale and design of interleukin-1 blockade in recently decompensated heart failure (REDHART2): a randomized, double blind, placebo controlled, single center, phase 2 study","volume":"20","author":"Van Tassell","year":"2022","journal-title":"J Transl Med"},{"key":"2026021804212697200_ehf215231-bib-0088","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1093\/ehjacc\/zuad102","article-title":"In-perspective: the ARAMIS double-blind randomized placebo-controlled trial of anakinra for the treatment of acute myocarditis","volume":"12","author":"Morrow","year":"2023","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"2026021804212697200_ehf215231-bib-0089","doi-asserted-by":"publisher","first-page":"409","DOI":"10.7326\/0003-4819-155-7-201110040-00359","article-title":"Colchicine for recurrent pericarditis (CORP)","volume":"155","author":"Imazio","year":"2011","journal-title":"Ann Intern Med"},{"key":"2026021804212697200_ehf215231-bib-0090","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1056\/NEJMoa2027892","article-title":"Phase 3 trial of Interleukin-1 trap rilonacept in recurrent pericarditis","volume":"384","author":"Klein","year":"2021","journal-title":"N Engl J Med"},{"key":"2026021804212697200_ehf215231-bib-0091","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/j.jacep.2022.10.032","article-title":"Inflammation on endomyocardial biopsy predicts risk of MACE in undefined left ventricular arrhythmogenic cardiomyopathy","volume":"9","author":"Peretto","year":"2023","journal-title":"JACC Clin Electrophysiol"},{"key":"2026021804212697200_ehf215231-bib-0092","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.jacbts.2023.02.018","article-title":"Multimodal detection and targeting of biopsy-proven myocardial inflammation in genetic cardiomyopathies","volume":"8","author":"Peretto","year":"2023","journal-title":"JACC Basic Transl Sci"},{"key":"2026021804212697200_ehf215231-bib-0093","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.jacbts.2021.07.012","article-title":"Translation of new and emerging therapies for genetic cardiomyopathies","volume":"7","author":"Helms","year":"2022","journal-title":"JACC Basic Transl Sci"},{"key":"2026021804212697200_ehf215231-bib-0094","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1161\/CIRCULATIONAHA.119.040676","article-title":"Therapeutic modulation of the immune response in arrhythmogenic cardiomyopathy","volume":"140","author":"Chelko","year":"2019","journal-title":"Circulation"},{"key":"2026021804212697200_ehf215231-bib-0095","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.acvd.2023.07.004","article-title":"Rationale and design of the ARAMIS trial: anakinra versus placebo, a double blind randomized controlled trial for the treatment of acute myocarditis","volume":"116","author":"Kerneis","year":"2023","journal-title":"Arch Cardiovasc Dis"},{"key":"2026021804212697200_ehf215231-bib-0096","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1161\/01.CIR.100.10.1102","article-title":"Treatment of experimental viral myocarditis with interleukin-10","volume":"100","author":"Nishio","year":"1999","journal-title":"Circulation"},{"key":"2026021804212697200_ehf215231-bib-0097","doi-asserted-by":"publisher","DOI":"10.1093\/ehjcr\/ytz131","article-title":"Targeting CD20+ B-lymphocytes in inflammatory dilated cardiomyopathy with rituximab improves clinical course: a case series","volume":"3","author":"Tsch\u00f6pe","year":"2019","journal-title":"Eur Heart J Case Rep"},{"key":"2026021804212697200_ehf215231-bib-0098","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.jacc.2016.11.009","article-title":"Randomized comparison of allogeneic versus autologous mesenchymal stem cells for nonischemic dilated cardiomyopathy: POSEIDON-DCM trial","volume":"69","author":"Hare","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2026021804212697200_ehf215231-bib-0099","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1084\/jem.20111009","article-title":"Rapid monocyte kinetics in acute myocardial infarction are sustained by extramedullary monocytopoiesis","volume":"209","author":"Leuschner","year":"2012","journal-title":"J Exp Med"},{"key":"2026021804212697200_ehf215231-bib-0100","first-page":"6066","article-title":"Immunomodulation by adoptive regulatory T-cell transfer improves coxsackievirus B3-induced myocarditis","volume":"32","author":"Pappritz","year":"2018","journal-title":"FASEB J Off Publ Fed Am Soc Exp Biol"}],"container-title":["ESC Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/12\/6\/3987\/66968191\/eschf_12_6_3987.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/12\/6\/3987\/66968191\/eschf_12_6_3987.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T09:21:33Z","timestamp":1771406493000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eschf\/article\/12\/6\/3987\/8488207"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,27]]},"references-count":100,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,11,27]]},"published-print":{"date-parts":[[2025,12,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ehf2.15231","relation":{},"ISSN":["2055-5822"],"issn-type":[{"value":"2055-5822","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,12]]},"published":{"date-parts":[[2025,11,27]]},"assertion":[{"value":"2024-07-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-01-14","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-27","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}